Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AACR 2012 /
Effects of metformin in pancreatic cancer with diabetes

31st Mar - 4th Apr 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 16.04.12
Views: 3489

Prof Donghui Li - University of Texas MD Anderson Cancer Center, Houston, USA

Prof Li talks about the new findings with the drug metformin in diabetic patients with pancreatic cancer. Preliminary data has shown that 117 patients who use metformin showed a 4-month increase in overall survival and 18 percent increase in first year survival.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation